血清胱抑素C和尿微量白蛋白测定在糖尿病肾病早期的临床价值探讨  

The Clinical Value of Serum Cystatin C and Microalbuminuria in Early Diabetic Nephropathy

作　　者：黄光武[1] 

机构地区：[1]四川省平昌县人民医院检验科,四川平昌636400

出　　处：《中国医药指南》2012年第24期399-400,共2页Guide of China Medicine

摘　　要：目的检测血清胱抑素C(Cystatin,Cys C)和尿微量白蛋白(Microalbuminuria,MAU),评价Cys C和MAU在糖尿病早期肾功能损伤的临床价值。方法收集60例2型糖尿病患者血清和晨尿,分别测定血清Cys C浓度和MAU浓度,与80例健康对照组进行比较。结果患者组与健康对照组的Cys C和MAU均有显著性差异(P<0.01)。结论 Cys C和MAU是临床诊断糖尿病患者肾功能早期损伤的特异而灵敏指标。Objective Detect serum Cystatin C and urinary albumin, in order to evaluate their clinical value in early diabetic renal injury. Methods To determine Cys C and MAU in 60 patients who have type 2 diabetes,and 80 healthy control group. Results significant difference was observed between patients and healthy people（P〈0.01）.Conclusion Cys C and MAU may be clinically utilized as a sensitive and reliability indicator of early diabetes renal dysfunction.

关 键 词：糖尿病肾病 胱抑素C 尿微量白蛋白 早期诊断 

分 类 号：R587.2[医药卫生—内分泌]